Antiphospholipid Syndrome (APS) Education

Michael D. Lockshin, MD

Attending Rheumatologist, Hospital for Special Surgery
Professor of Medicine, Weill Cornell Medical College
Director, Barbara Volcker Center for Women and Rheumatic Disease

In this presentation, Dr. Lockshin provides an explanation of antiphospholipid syndrome (APS) and how it can be treated. He then answers questions submitted by patients in attendance.

Posted: 5/26/2009

Departments and Services

Rheumatology

Clinical Trials

PROMISSE: Predictors of Pregnancy Outcome: Biomarkers in Anti-Phospholipid Antibody Syndrome (APS) and Systemic Lupus Erythematosus (SLE)
Cognitive Dysfunction, Diffusion Tensor Imaging and Functional Magnetic Resonance Imaging (MRI) in Antiphospholipid Antibody (aPL)-negative Systemic Lupus Erythematosus (SLE) versus aPL-positive non-SLE Patients
Autoimmune Disease Registry and Repository
Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients with and without Systemic Lupus Erythematosus
RITAPS: A Pilot Study Of Rituximab For The Anticoagulation-Resistant Manifestations Of Antiphospholipid Syndrome (APS)
Effects of Fluvastatin on Proinflammatory and Prothrombotic markers in Antiphospholipid Syndrome

Newsroom

Rituximab Shows Promise for Clinical Problems Tied to Antiphospholipid Antibodies

Contact HSS
Give to HSS
Maps and Directions
Notice of Privacy Practices
Terms of Use
Joint Commission Notice
HSS Staff Login

Antiphospholipid Syndrome (APS) Education

Michael D. Lockshin, MD

Departments and Services

Related Patient Articles

Clinical Trials

Newsroom